Fluorouracil -LENS - User , application , reviews


1. active substance

2. Product form

3. Composition

4. Indications

5. Contraindications

6. dosage and Administration

7. Side effects

8. Cautions

9. Terms and Conditions of storage

Fluorouracil-LENS - uracil antimetabolite having anticancer activity.

active substance

Fluorouracil (Fluorouracil)

Product form

The drug is available as a solution for intracavitary and intravascular injection of 250 mg / 5 ml.The solution is implemented in ampoules 5 ml each, into cartons (10, 25, 35 and 50 vials each).


1 ml

1 amp.


50 mg

250 mg


Fluorouracil-LENS is assigned to the following pathological conditions:

  • Malignantswelling of the neck and head.
  • Breast Cancer.
  • cancer rectum and colon.
  • Cancer of the pancreas, stomach and esophagus.
  • primary liver cancer.
  • Bladder Cancer.
  • adrenal cancer.
  • cervical cancer and ovarian cancer.
  • Cancer of the penis.
  • Prostate Cancer.
  • carcinoid.

Contraindications Contraindications to the use of the drug:

  • Severe thrombocytopenia, neutropenia, leukopenia.
  • Stomatitis.
  • pseudomembranous enterocolitis.
  • ulceration of the mucous layer of the gastrointestinal tract.
  • Pregnancy and lactation.
  • hypersensitivity to the drug.

With extreme caution Fluorouracil-LENS is prescribed for acute infectious diseases of bacterial, fungal and viral etiology (including tuberculosis, herpes zoster, chickenpox), infiltration of the tumor of the bone marrow cells before chemotherapy or radiation therapy, as well as athepatic and renal failure.

Dosage and Administration

Fluorouracil is included in the composition of many chemotherapy regimens, so when choosing a dose and mode of administration in each individual case should be guided by the special literature.The drug is administered intravenously, intraarterially, intracisternally and by slow infusion.

Recommended doses and regimens:

  • 12-13.5 mg / kg or 500 mg / m 2 daily for 3-5 days.The break between courses - 4 weeks.
  • 15 mg / kg or 600 mg / m2 weekly, doses of 6-10.The maximum allowable single dose of 1 g
  • 600 mg / m2 intravenously at days 1 and 8 in combination with other cytostatics.
  • 1 g / m2 per day intravenously.Infusion duration ranging from 96 to 120 hours.When combined with fluorouracil-folinic acid dose is usually first reduced by 25-30%.

Side effects

application of fluorouracil-LENS can cause the development of the following adverse reactions:

  • Digestive system: nausea, vomiting, decreased appetite, diarrhea, change in taste, heartburn, ulceration or inflammation of the mucosa of the gastrointestinal tract,gastrointestinal bleeding, abnormal liver work.
  • Nervous system: rarely - a violation of the sensitivity, cerebellar ataxia, confusion, disorientation, nystagmus, euphoria, headache, optic neuritis.
  • Cardiovascular system: very rarely - arrhythmias, chest pain, ischemia, angina, myocardial infarction, heart failure.
  • Reproductive System: disruption of the sex glands, resulting in amenorrhea or azoospermia.
  • hematopoietic system: neutropenia, leukopenia (9 and 14-25 days of treatment);rarely - anemia, thrombocytopenia (7 to 17 days of therapy).
  • skin and skin appendages: skin hyperpigmentation, alopecia, cracked and dry skin, hand-foot syndrome eritrodizestezii, convergence and change of nail plates, photosensitivity.
  • Senses: excessive tearing, eye irritation, blurred vision, cataract, photophobia, cortical blindness.
  • Allergic reactions: flushing of the skin of palms and soles, hives, skin rashes, dermatitis, bronchospasm, anaphylaxis.
  • Other: thrombophlebitis at the injection site, fever, development of secondary infections, hyperuricemia, epistaxis, fatigue, shortness of breath, cough.


Since Fluorouracil-LENS is a cytostatic, then you must treat it with extreme caution.

If you have diarrhea or stomatitis therapy should be discontinued until symptoms data.

Patients previously treated with alkylating drugs or exposed to large doses of radiation during treatment must be careful.

The initial dose should be reduced by 30-50% in the following situations: post-operative period less than 30 days after the complicated surgery, weight loss, disruption of the kidney and liver, impaired bone marrow function.

Men and women of childbearing age during treatment, as well as after it (for 3 months) should use reliable contraceptives.

During therapy need to regularly inspect the oral cavity of the patient to identify stomatitis, determine hemoglobin, hematocrit, bilirubin level and the activity of liver function tests, as well as control the number of white blood cells, platelet count and absolute neutrophil count.

Side effects provoked by the use of fluorouracil-LENS, may adversely affect the performance of work requiring speed of psychomotor reactions, and road management capabilities.

Conditions and terms

Store in a dark and protected from children, at a temperature range - from 15 to 25 ° C.Shelf life - 2 years.


Product description posted on this page is a supplement and a simplified version of the official version of the annotations to the drug.The information is provided for informational purposes only and is not a guide to self-medication.Before using the product you should consult with a specialist and to get acquainted with the instructions approved by the manufacturer.

Latest Blog Post

Vitamins Multi-tabs for children - a dietary supplement reviews
August 12, 2017

Contents: 1. composition of vitamins multi-tabs 2. Application Multi-tabs - a dietary supplement based on vitamins A, B, C,D a...

The drug Mulimen - instruction , application reviews
August 12, 2017

Contents: 1. Pharmacological action Mulimena 2. release form and composition 3. Indications Mulimena 4. Application Mulimena ...

Mukofalk - instruction , application reviews
August 12, 2017

Contents: 1. Pharmacological action 2. Indications Mukofalk 3. Dosing Mukofalk on instructions 4. Contraindications 5. Si...